-
First Patient Dosed in Phase 2 Clinical Study of Drug for Pleural Mesothelioma
Biotechnology company RS Oncology has announced the start of a new Phase 2 clinical study of its drug, RSO-021 for the treatment of malignant pleural mesothelioma and other thoracic malignancies, and the successful first dosing of a patient. The multicenter study based in the United Kingdom is evaluating the drug’s impact on patients suffering the
-
J&J’s Attorneys Question Ovarian Cancer Talc Victims’ Reliance on Mesothelioma Study
Johnson & Johnson is currently facing over 40,000 personal injury claims blaming its talc for cases of ovarian cancer and malignant pleural mesothelioma. At issue is whether the product causes these illnesses and whether the company was aware of its dangers. As multidistrict litigation exclusively filed by ovarian cancer victims is set to begin in
-
Novel Defense in Asbestos Lung Cancer Lawsuit Defeated
In 2019, Francesco Carboni died of asbestos-related lung cancer. His widow, Susan, blamed the asbestos he was exposed to as a result of his work as an auto mechanic for his exposure and blamed multiple companies. Included among them was a company operating as Alfa Romeo USA. After years of participating in the litigation, the
-
Welder’s Mesothelioma Blamed on Asbestos in Safety Gloves
Mario Caligiuri blames his mesothelioma diagnosis on the asbestos he was exposed to during his career as a welder. When filed a personal injury lawsuit against companies whose asbestos-contaminated products he used or was exposed to, he included Olympic Glove & Safety Co., Inc. whose gloves he wore in the 1970s. Olympic filed a motion
-
Colgate Palmolive’s Attempt to Dismiss Mesothelioma Claim Called “Substantively Defective”
Last October, Paula Corin filed a personal injury claim against forty-three different companies, blaming them for exposing her to the asbestos that caused her malignant pleural mesothelioma. Her suit was filed in the Los Angeles County Superior Court, and the day after she filed, Colgate-Palmolive removed the case to the U.S. District Court on the
-
Study Reveals Benefit of Combining Pembrolizumab with Chemotherapy for Pleural Mesothelioma
Immunotherapy treatment has become one of the greatest sources of optimism for patients with cancers of all types, including mesothelioma. A group of international researchers recently released the findings of their study investigating combining one immunotherapy drug, pembrolizumab, with the gold standard chemotherapy treatment for the rare asbestos-related disease and found that it significantly improved patients’
-
Second-Hand Asbestos Exposure Blamed for Woman’s Mesothelioma Death
Roseanna Matherne died of malignant pleural mesothelioma after years of laundering her husband’s asbestos-contaminated work clothes. Her family blamed the Avondale Shipyard for failing to warn and failure to implement appropriate safety measures that would have prevented her secondary exposure. When the company tried to advance a government contractor defense, Mrs. Matherne’s family moved for partial
-
Asbestos Companies’ Legal Strategy in Mesothelioma Claims Spurs Action from Senators
Mesothelioma victims and others exposed to asbestos are well aware that some of the country’s biggest and most successful companies, including Georgia-Pacific and Johnson & Johnson have turned to a questionable legal strategy to evade liability for their negligence. In the face of thousands of victims being prevented from seeking justice, three U.S. senators and
-
Insurance Company’s Attempt to Shut Down Mesothelioma Claim Fails
When a mesothelioma victim or their family member decides to file a personal injury lawsuit against those they blame for their illness, the claim can include all parties involved, from the mine where the asbestos originated to the manufacturer and sellers of the asbestos-contaminated products and their insurance companies. These companies frequently use multiple legal
-
Japanese Physicians Warn Against First Line Nivolumab Plus Ipilimumab in Elderly Mesothelioma Patients
Malignant mesothelioma is a rare and deadly form of cancer most frequently diagnosed decades after its victims are exposed to asbestos. The long latency means that the median age at diagnosis is 76 years old. Though immunotherapy treatment of nivolumab plus ipilimumab has provided superior survival outcomes as a first-line treatment for the disease, Japanese
-
Portugal Hospital Reports Complete Response to Immunotherapy for Peritoneal Mesothelioma Patient
This morning, an article appeared in a respected medical journal reporting on a complete response to the immunotherapy drug pembrolizumab in a patient with malignant peritoneal mesothelioma. The case study’s authors encourage the drug’s use, despite the lack of evidence to support the treatment.
-
Oregon Mesothelioma Victim’s Survivors Succeed in Returning Claim to State Court
When Elsie Louise Graham died of malignant mesothelioma, her family filed suit against numerous defendants they accused of exposing her to asbestos through the talcum powder products, including the owner of a local market where she had purchased the powders. In response, the consumer giants named in the case argued that the case should be
-
New Construction Industry Study Reveals Mesothelioma Risk from Aging Asbestos Water Pipes
A new report released by Occupational Knowledge International confirmed what mesothelioma experts and advocates have long known: construction workers face ongoing risk from asbestos concrete products, particularly from aging asbestos concrete water pipes.
-
Mesothelioma Verdict Overturned Based on Court’s Abuse of Discretion
The family of a man who died of malignant mesothelioma in 2012 will have another chance at justice after an appeals court agreed that the trial court hearing their original claim abused its discretion in ruling that an elderly witness had to testify in person. The Appellate Court of Illinois ruled that refusing the witness
-
European Union Issues New Asbestos Rules to Prevent Future Mesothelioma
In recognition of asbestos’ role in malignant mesothelioma and the continued danger posed by exposure to the carcinogenic mineral, the European Union has taken action to strengthen its previously existing Directive. The new rules will ensure better protection for those who are exposed to dust from asbestos or materials containing it during their work.
-
Glove Manufacturer’s Attempt to Evade Mesothelioma Claim Fails in New York Court
After multiple attempts to evade responsibility for seaman Giacinto Pira’s death, glove manufacturer Steel Grip’s motion for summary judgment in his family’s claim against them was “denied in its entirety” by Justice Adam Silvera of the Supreme Court of New York County.
-
Report Details Drop in Mesothelioma Death Incidence Rate
A study published in a recent edition of the Annals of the American Thoracic Society reports a significant drop in malignant mesothelioma mortality rates between 1990 and 2019. The study’s authors conclude that the decrease in global age-standardized incidence of the asbestos-related disease is due to improvements that have been made in worldwide occupational settings.
-
Asbestos-contaminated Printing Presses Blamed for Man’s Mesothelioma
Mesothelioma victim Raymond Desiena worked as a printing press operator from the 1960s to the 1980s. Before his death, he filed personal injury lawsuits against two printing press companies: he blamed them for exposing him to asbestos-containing parts in their equipment without providing him with warnings of the dangers that they posed. Though both companies filed
-
Louisiana Mesothelioma Victim Accuses Talc Companies of Conspiracy
When Louisiana resident and mesothelioma victim Michael Simoneaux added two well-known talc companies as defendants in the asbestos claim he’d filed against his former employers, he based his claim against them on charges of conspiracy. Both Johnson & Johnson and Mennen Company filed a motion to have the conspiracy claim dismissed, but Judge Jay C.
-
Fireproofing Materials Used in World Trade Center Construction Blamed for Mesothelioma
In an ongoing lawsuit being heard in the Supreme Court of New York, mesothelioma widow Marie Bassi Ryder has filed a personal injury claim against multiple companies that she accuses of having exposed her late husband to asbestos. One of those companies, Arconic, Inc., filed a motion to have the claim against them dismissed, but
